• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肿瘤中倍体水平的预后意义。II. 子宫外癌症及1171例肿瘤数据总结

Prognostic significance of ploidy level in human tumours. II extra-uterine cancers and summary of data on 1171 tumours.

作者信息

Atkin N B

出版信息

Cytobios. 1976;15(60):233-7.

PMID:1035153
Abstract

The 5-year survival rate of 78 patients with carcinoma of the ovary showed that the prognosis was significantly better when the tumour modal DNA value was in the diploid region than when it was near-triploid or above. Similar data on 140 patients with carcinoma of the breast and 52 with carcinoma of the bladder also suggested a better prognosis for the near-diploid tumours. Among 105 carcinomas of the large bowel, however, there were more survivors in the high-ploidy than in the near-diploid group, although the difference was not statistically significant. The varying relationship between ploidy and prognosis, depending on the site or histological type of the tumour, is briefly discussed on the basis of the 1171 cases included in the present and a previous paper.

摘要

78例卵巢癌患者的5年生存率表明,肿瘤模态DNA值处于二倍体区域时的预后明显好于接近三倍体或高于三倍体时。140例乳腺癌患者和52例膀胱癌患者的类似数据也表明,接近二倍体肿瘤的预后更好。然而,在105例大肠癌中,高倍体组的存活者比接近二倍体组更多,尽管差异无统计学意义。基于本文及之前一篇论文中纳入的1171例病例,简要讨论了倍体与预后之间因肿瘤部位或组织学类型而异的关系。

相似文献

1
Prognostic significance of ploidy level in human tumours. II extra-uterine cancers and summary of data on 1171 tumours.人类肿瘤中倍体水平的预后意义。II. 子宫外癌症及1171例肿瘤数据总结
Cytobios. 1976;15(60):233-7.
2
[DNA examinations in gynecological cancer and breast cancer].[妇科癌症和乳腺癌中的DNA检测]
Tidsskr Nor Laegeforen. 1991 May 20;111(13):1638-42.
3
Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.卵巢癌的肿瘤倍体、形态测定、组织学分级及临床特征:相互关系
Anal Cell Pathol. 1991 Sep;3(5):261-71.
4
[Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].[联合流式细胞术测定S期分数和DNA倍体是淋巴结阴性浸润性乳腺癌的独立预后因素:对271例I期和II期乳腺癌患者的系列研究回顾]
Cancer Radiother. 2005 Dec;9(8):575-86. doi: 10.1016/j.canrad.2005.09.016. Epub 2005 Oct 20.
5
Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
Cancer. 1996 Oct 15;78(8):1748-55.
6
Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.联合流式细胞术测定S期细胞比例和DNA倍体是淋巴结阴性浸润性乳腺癌的独立预后因素:对271例I期和II期乳腺癌患者的系列分析
Breast Cancer Res Treat. 2005 May;91(1):61-71. doi: 10.1007/s10549-004-7047-1.
7
[Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].[结直肠癌预后参数的评估。II. 流式细胞术检测倍体]
Pathologica. 1994 Feb;86(1):30-42.
8
Prognostic value of DNA ploidy in breast cancer stage I-II.I-II期乳腺癌中DNA倍体的预后价值
Neoplasma. 1997;44(2):127-32.
9
DNA ploidy as a prognostic factor in patients with ovarian carcinoma.DNA倍体作为卵巢癌患者的预后因素。
Pol J Pathol. 1998;49(3):141-4.
10
[DNA flow cytometry: perspective prognostic parameters in carcinoma of the uterine cervix].[DNA流式细胞术:子宫颈癌的前瞻性预后参数]
Cesk Gynekol. 1992 Apr;57(2):49-55.

引用本文的文献

1
Should flow cytometric DNA analysis precede definitive surgery for colon carcinoma?流式细胞术DNA分析是否应在结肠癌根治性手术之前进行?
Ann Surg. 1985 Dec;202(6):740-4. doi: 10.1097/00000658-198512000-00014.
2
DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.T1和T2期口腔癌的DNA含量、恶性分级及预后
Br J Cancer. 1987 Nov;56(5):647-52. doi: 10.1038/bjc.1987.260.
3
DNA index--parameter for the prediction of prognosis and primary radioresistance?DNA指数——预测预后和原发性放射抗性的参数?
J Cancer Res Clin Oncol. 1990;116(4):315-7. doi: 10.1007/BF01612911.
4
The heterogeneity of solid human xenotransplant tumours.人类实体异种移植肿瘤的异质性。
J Cancer Res Clin Oncol. 1991;117(6):568-74. doi: 10.1007/BF01613290.
5
Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases.基于1465例病例探讨恶性肿瘤中DNA含量众数及其他因素的预后意义。
Br J Cancer. 1979 Aug;40(2):210-21. doi: 10.1038/bjc.1979.168.